Refractory Colorectal Carcinoma (DBCOND0110136)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT03800602 Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer treatment 2 completed NCT03576963 Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer treatment 1 / 2 withdrawn NCT03436563 M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability treatment 1 / 2 active_not_recruiting NCT02873195 Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer treatment 2 completed NCT03610490 Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma treatment 2 terminated NCT04294264 TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer treatment 2 active_not_recruiting NCT02983578 Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer treatment 2 active_not_recruiting NCT05733000 CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors treatment 2 recruiting NCT03844620 Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer treatment 2 active_not_recruiting NCT02595931 M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT06221423 Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer Not Available Not Available recruiting